Abstract
This document reviews the most relevant mass spectrometry approaches to selenium (Se) speciation in high-Se food supplements in terms of qualitative and quantitative Se speciation and Se-containing species identification, with special reference to high-Se yeast, garlic, onions and Brazil nuts. Important topics such as complexity of Se speciation in these materials and the importance of combining Se-specific detection and molecule-specific determination of the particular species of this element in parallel with chromatography, to understand their nutritional role and cancer preventive properties are critically discussed throughout. The versatility and potential of mass spectrometric detection in this field are clearly demonstrated. Although great advances have been achieved, further developments are required, especially if “speciated”certified reference materials (CRMs) are to be produced for validation of measurements of target Se-containing species in Se-food supplements.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Selenium (Se) is a crucial nutrient for higher organisms including humans. It is a component of a number of important Se-containing proteins and enzymes required for such functions as antioxidant defence, reduction of inflammation, thyroid hormone production, DNA synthesis, fertility and reproduction [1, 2]. Se requirements can be satisfied by 0.1 mg kg-1 of the diet [3]. On the basis of this estimate, daily Se intakes for humans that vary according to the country or region, age and sex have been recommended and recently compiled by Rayman [4]. However, the dose at which selenium has to be taken is very critical, as Se can be toxic at levels little above those required for health [5–8].
Recent studies have shown that Se supplementation in the diet can reduce the risk of several forms of cancer (in humans and animals) [9–22] and other human diseases and may prevent the development of AIDS in HIV-positive individuals [2]. The interest in Se as a food supplement and the marketing of it to the public has therefore increased in recent years.
Se supplements commercially available include the inorganic forms, sodium selenite, sodium hydrogen selenite and sodium selenate and the organic forms, selenomethionine (SeMet), selenium-methyl-Se-cysteine (SeMC) and Se-enriched yeast [23]. SeMet is the principal form of Se in most foods and is well absorbed and stored within the human body [24]. The Se ingested as free SeMet (major component of Se-yeast) or selenised yeast has been shown to be more bioavailable than selenite in lactating rats [25]. In these studies, selenium bioavailability of the Se compounds was estimated not only on the basis of determination of Se absorption but also on the measurements of tissue Se concentration and glutathione peroxidase activities. Fractional absorption and retention of SeMet and Se-yeast in humans [26–30] were found to be higher than those of inorganic Se; inorganic selenium is generally excreted more rapidly and is more toxic than SeMet. The SeMC, a naturally occurring selenoamino acid synthesised by garlic, broccoli and onions, has been shown to be more efficacious than the most extensively studied organoselenium compounds (e.g. SeMet) in mammary cancer chemoprevention in rats [14, 15]. More recently, it has become available to the public as a dietary supplement of Se due to the great efficacy as a chemopreventive agent that this Se species has shown in experimental models of breast cancer and its promising potential for use in human populations [16].
The anti-carcinogenic effects of Se have been associated with certain Se-metabolites such as methylselenol (CH3SeH) [31–35]. However, the relationship and mechanism by which Se supplementation may reduce certain cancer risks is not fully understood. Absorption, tissue distribution, bioavailability, and cancer preventive properties depend on the chemical species in which Se occurs in food and supplements.
A typical metabolic fate of SeMet and other organic Se compounds from the human diet (e.g. selenocysteine (SeCys) and SeMC), as shown in Fig. 1, emphasises the complexity of Se speciation [4]. SeMet from Se-enriched food supplements (e.g. Se-yeast) and food proteins can be incorporated non-specifically into proteins such as albumin and haemoglobin by replacing methionine (Met). Alternatively, after being released from the protein pool, it can be transformed via SeCys to hydrogen selenide (H2Se) [36]. The metabolism of SeMC species, mostly studied in animals, indicates that SeMC is not incorporated into any proteins in place of Met. It can be thus easily used for the synthesis of Se-containing enzymes as well as converted to metabolites such as methylselenol, which is thought to be potently anti-carcinogenic as stated above. Gamma-glutamyl-SeMC, recently identified as the major Se-compound in natural garlic and selenised garlic and onion, serves primarily as a carrier of SeMC [36]. Oxidised inorganic forms of selenium undergo reductive metabolism yielding H2Se, the starting point for the production of selenoproteins [4]. Excess Se is detoxified by successive methylation of H2Se, yielding methylselenol (CH3SeH), dimethyl selenide ((CH3)2Se) and trimethyl selenonium ion ((CH3)3Se+), the latter two of which are excreted in breath and urine, respectively. Identification of (CH3)3Se+ as the main Se product in urine is based on experiments with rats [35] after administration of large doses of Se. However, new studies involving the identification of Se compounds in urine by MS techniques have shown that the main Se metabolite in rats urine as well as in human urine, after Se supplementation in sub-toxic doses, is Se-methylseleno-N-acetylgalactosamine [37–39]. More recently, two minor metabolites were identified as Se-methylseleno-N-acetylglucosamine and Se-methylselenogalactosamine in human urine from individuals who had been supplied with Se as Se-yeast [40]. The latter appeared to be one of the main metabolites in basal human urine from individuals who were not supplied with Se.
The speciation analysis of inorganic and organoselenium compounds in food supplements is desirable, to define biological roles and cancer prevention efficacy and to assure batch-to-batch reproducibility in these products. This requires the development of “state of the art” mass spectrometric techniques capable of identifying and determining selenium species in Se-enriched food matrices and in samples with natural Se concentration levels (control samples) [41]. The measurement of the low concentrations of the element, associated with minor species, in the complex biological matrices and prevention of species transformation during the analysis are considered to be the main challenges.
Selenised yeast has probably been the most widely investigated food supplement containing Se [4, 9, 41–78]. It is the only form of Se to date to have shown efficacy as an intervention agent in human cancer prevention studies [9, 76, 77]. To a lesser extent, different species of Allium plants (Se-enriched garlic and Se-enriched onion) have also been investigated as dietary supplements because of their perceived medical value, especially in the context of cancer and anticardiovascular diseases [79–92]. Other dietary Se sources are Brazil nuts since these foodstuffs can contain very high levels (as high as 35 μg g-1) of naturally occurring Se [93–98]. The efficacy of selenium, delivered naturally in this food form, in cancer chemoprevention was demonstrated in experiments with rats [97, 98]. Much effort has been devoted to characterisation of these materials in terms of species quantitation and identification and isotopic composition determination (the last only applies to isotopically enriched Se-yeast). Modern MS approaches to Se speciation in the above-mentioned dietary supplements are reviewed in this paper. Moreover, different extraction protocols are compared in terms of Se extraction yield and preservation of the identity of Se-compounds. Applications of chromatography with Se-specific and molecule-specific detection for the analysis of dietary sources of Se are summarised in Table 1.
Modern trends in the speciation analysis of Se in high-Se yeast by hyphenated techniques
Cereals and forage crops convert Se mainly into SeMet and incorporate it into proteins in competition with Met. In a similar manner, Saccharomyces cerevisiae (baker’s yeast) may assimilate during its growth up to 3000 μg g-1 Se as selenite, which is converted into a safer and highly bioactive species with improved nutritional properties, the major product being SeMet [44].
Se-yeast is attractive as a supplementary source of Se owing to its low cost, its ability to act as a precursor for selenoprotein synthesis and its high content of SeMet, a form of Se found in most foods. However, the variability of Se-yeast with respect to Se content and speciation and the lack of knowledge of the identity of the Se species that occur in this food supplement remain a problem. There is therefore an essential need to characterise and quantify the Se-species present in selenised yeast.
The literature on the Se speciation analysis of selenised yeast is abundant (see Table 1) and has been, to some extent, reviewed [4, 41, 42]. The analytical methods used have been based on the coupling of liquid chromatography (usually size-exclusion followed by ion-exchange and ion-pair reversed-phase HPLC) [48–51], gas chromatography [52, 53], capillary electrophoresis [54], and 2D gel electrophoresis (for Se-containing proteins) [55] with Se-specific detection, usually by inductively coupled plasma mass spectrometry (ICP-MS). Electrospray ionisation (ESI) MS [56–58] and matrix-induced laser desorption ionisation (MALDI) MS [58, 73] have been used for the confirmation and/or identification of Se-compounds detected. The GC-MS has been used for molecular mass determination of Se-amino acids after their extraction from yeast and derivatisation [52, 68].
Despite the increasing number of publications about the speciation of Se in high Se-yeast, the preservation of the identity of the Se-compounds during their extraction from the solid matrix prior to their analysis using chromatography and mass spectrometry techniques remains a challenge. Water has been used for extraction of the intact low and high molecular weight compounds from the solid sample prior to their analysis using MS techniques [48–50]. Unfortunately, the extraction efficiency with this method was low (10–20% of the total Se in yeast was found in the water-soluble fraction). Alternatively, extraction of cell-wall bound compounds has been achieved by using cell-wall degrading enzymes (e.g. Driselase) [49]. To characterise membrane-protein containing Se, leaching with sodium dodecylsulphate (SDS) was utilised [49]. To release the Se-compounds from proteins, which are present in any of the yeast fractions, enzymatic [47, 49, 51, 59, 60, 93] or, to a lesser extent, acid digestions [3, 42, 89] were carried out. Table 2 summarises the extraction efficiency of Se from Se-yeast as a result of various extraction methods. A critical comparison of extraction methods for quantification of SeMet and Met in yeast has recently been reported by Yang et al. [70]. The enzymes used in most digestion protocols are Proteinase K and Protease XIV [49, 94]. Digestion with enzymes has led to 55–85% [45, 47, 51, 52, 62, 69] recovery of the total Se content in the dry yeast (mostly found as SeMet). The extraction efficiency of the enzymatic methods of hydrolysis critically depends on the type of enzyme and the extraction conditions (e.g. incubation time and sample to enzymes ratio), as demonstrated by Yang et al. [70]. Furthermore, the SeMet content/total Se value (used for calculation of the extraction efficiency) might be dependent on the source of yeast analysed and can be affected by the degree of oxidation of SeMet during the entire analytical procedure. Therefore large variations in extraction efficiencies for SeMet with different enzymatic protocols have been reported for yeast-based materials [45, 47, 51, 52, 62, 69, 70]. A more efficient liberation of SeMet from yeast was observed by hydrolysis with methanesulphonic acid compared to the most commonly used enzymatic approaches [72, 93]. A different technique, using cyanogen bromide to liberate SeMet from yeast was reported by Wolf et al. [71]. However, the incomplete degradation of proteins with cyanogen bromide could possibly cause the low extraction efficiency observed with this method, as shown by results from a recent study [72].
In terms of species identification, consistent results have been reported for some Se compounds in yeast using MS techniques. With size-exclusion LC-ICP-MS, supported by peptide mapping approaches and atmospheric pressure ionisation MS, SeMet was found as the major Se species in yeast. In contrast to previous findings, a large part of it was found to be physically associated with a number of macromolecules, especially cell wall constituents rather than bound into Se-containing proteins [49]. The combination of orthogonal size exclusion-reversed-phase chromatography with ICP-MS and MALDI TOF MS or ESI-MS/MS allowed for the identification of a family of Se-containing proteins; a salt stress-induced protein SIP-18 (Mr 8874) and a heat-shock protein HSP12 (Mr 11693) and of a low molecular weight compound Se-adenosyl-homoselenocysteine in the water-soluble extract [49, 50]. More recently, the potential of MALDI tandem (Q/TOF) MS for the speciation of Se in selenised yeast aqueous extracts was investigated and compared with that of ESI tandem MS [73]. The MALDI was found to offer a competitive performance to ESI tandem MS for the identification of non-peptide Se species in yeast extracts, owing to its ability to handle minute volumes of samples with complex matrices. An unknown Se compound with a molecular mass of 388 u was detected and the product ion spectrum from the precursor ion (m/z 388) was obtained. However, the MS data alone did not provide enough evidence of structural confirmation [73].
Using size-exclusion chromatography and ESI-MS/MS, McSheehy et al. [48] found three new Se-containing species with molecular masses of 562, 584 and 603 u in aqueous selenised yeast extracts. The authors demonstrated by collision-induced dissociation (CID) that these compounds contain a Se-S bridge between glutathione and three unidentified Se-compounds. Another Se species with a molecular mass of 372 u was shown to contain glutamine, but also could not be completely identified.
Identification of SeMet as the main compound in enzymatic yeast extracts by combination of chromatography with ICP-MS and on-line ESI-MS has been accomplished by Uden and co-workers [56]. With no fragmentation of the molecular ion possible, the identification was only based on retention time matching with authentic standards and the molecular weight of the species. Structural characterisation of SeMet in yeast enzymatic digests was recently accomplished by on-line ion-pair reversed-phase HPLC with ICP-MS and ESI-MS/MS detection [78]. The CID was used to obtain the product ion spectrum of the m/z 198 precursor ion for the SeMet peak. The MS results were consistent with the presence of SeMet in the yeast digests. Other attempts to identify SeMet and its oxidation product (SeOMet) in the unpurified enzymatic yeast hydrolysates by on-line cation-exchange HPLC and ESI-MS were not successful, possibly due to the ionisation suppression by the sample matrix in the ES ion source [61].
The presence of some Se species such as SeMC, selenocystine (Se(Cys)2), selenite, γ-glutamyl-Se-methyl-SeCys (γ-glutamyl-SeMC), Se-cystathionine and Se-lanthione in Se-yeast extracts has been detected by chromatography and ICP-MS on the basis of comparison of retention times with a matching standard [52, 61, 62]. However, verification of these species by molecule-specific mass spectrometry was not possible because of the low concentrations and matrix, which affected ionisation. Note that although assignments based on retention times suggest the presence of SeCys2, it is unlikely that this Se species occurs in yeast because of the absence of the UGA codon, which initiates the biosynthesis of the SeCys monomer, in the yeast genome [51]. In such a case, the use of complementary chromatographic methods combined with ICP-MS to achieve a selective separation/detection [51] and/or of molecular information has proven to be essential for verification of retention based identification. For SeMC, verification of its presence in yeast digests on the basis of retention time, molecular mass determination for the [M+H]+80 Se ions (m/z 184) and detection of its product ions by ESI-MS/MS was recently reported by Goenaga-Infante et al. [78]. To do this it was necessary to develop an efficient sample cleanup method prior to analysis by on-line ion-pair reversed-phase HPLC with ESI tandem MS. However, the sensitivity of the RP-IP HPLC-ESI-MS/MS method was found still poor, probably due to the lack of compatibility of TFA (ion-pairing reagent) with ESI, which is known to affect the on-line mass spectral confirmation of Se-compounds by molecule-specific techniques with ESI source. The presence of SeMC is of interest, as this species is believed to be metabolised in animals and humans to methyl selenol (CH3SeH), which appears to be a key anti-tumorigenic metabolite as stated above.
The use of ion-pair reversed-phase HPLC with ICP-MS and gas chromatography (after derivatisation of selenoamino acids) with atomic emission detection (AED) was useful for the detection of both SeMet-Se-oxide and Se-S bonded S-(selenomethyl)-cysteine (previously unidentified species) in archived nutritional yeast [52]. Confirmation of the presence of Se-S bonded S-(selenomethyl)-cysteine in the yeast sample was achieved using GC-MS.
Lindemann and Hintelmann [63] used nanoelectrospray MS to improve the detection power of Se compound identification in yeast extracts. The use of two-dimensional liquid chromatography combined with ICP-MS and off-line nanoelectrospray tandem MS enabled identification of Secontaining Glutathione S-Conjugates (selenodiglutathione and the mixed selenotrisulphide of glutathione and cysteinylglycine) in aqueous yeast extracts.
Two-dimensional gel electrophoresis for protein separation followed by laser ablation-ICP-dynamic reaction cell-MS for Se detection and protein characterisation by ESI-MS was reported and enabled the characterisation in terms of molecular mass, of up to 10 Se-containing proteins [55]. The strategy showed a promising potential for application to the possible establishment of a 2D reference map for Se-containing proteins in yeast. However, despite the high level of Se incorporation (0.2%), this [5] and other recent MS approaches [50, 66] have yielded limited results with respect to the elucidation of the incorporation of SeMet (presumably non-specifically incorporated into protein in the place of Met) in the yeast proteome. This has been attributed to the low abundance of the SeMet residues; a third of the Met residues, which have a relatively low abundance (about 1–2% of all amino acid residues) in the yeast proteome, are present as SeMet in Se-yeast [68]. This low abundance makes the identification of proteins, in which SeMet is incorporated, challenging. McSheehy et al. [75] have recently provided definitive evidence for the non-specific incorporation of SeMet in the yeast proteome using a two-dimensional liquid chromatography-MS based proteomic approach. By comparing the product ion spectrum of the precursor molecular ion for a Met-containing peptide (as previously identified in a LC fraction of a protein tryptic digest) with that of the same precursor molecular ion plus 48 mass units (the difference between the most abundant isotopes of S and Se), the presence of SeMet in the peptide could be confirmed if ‘matching’ spectra were observed. Moreover, the detection of the characteristic Se isotopic pattern helped in the identification of Se-containing peptides. The results suggested that the yeast support a high degree of SeMet incorporation (by replacement of about 30% of all Met with SeMet). However, the application of this approach to identification of proteins in yeast is restricted to higher abundance proteins with a relatively high Met content in sequence.
In terms of quantitative speciation of Se and determination of Se isotopic composition (of isotopically enriched Se-yeast), the attractive features of collision cell ICP-MS instruments (high sensitivity, selectivity and absence of spectral interferences that affect the ICP-MS detection of the most abundant Se isotopes) have been exploited in combination with chromatography for the analysis of yeast extracts [51, 60, 69]. Although most quantification approaches are based on calculations of percentage Se distributions, as expressed as the total Se area response of eluted peaks [51, 52], species-unspecific isotope dilution (ID) has recently been used in combination with collision cell ICP-MS for accurate quantitative determination of different Se-containing species in yeast enzymatic digests [60]. Species-specific isotope dilution analysis in combination with HPLC-ICP-MS [69], GC-ICP-MS and GC-MS [68, 71, 72] has recently been proposed for the accurate determination of SeMet in Se-yeast. With the latter approach the simultaneous determination of SeMet and Met was achieved using 13 C-enriched SeMet (available from Sigma, St.Louis MO, USA) and Met spikes [68]. This has found promise in the study of the incorporation rate of Se into the yeast proteome [68, 75].
Despite the increasing use of isotope dilution techniques for validation of methodologies for Se speciation analysis, the accurate determination of Se-compounds identified in Se-yeast, other than SeMet, still remains a challenge. This is due to the lack of commercially available isotopically enriched Se-containing species (to perform IDMS) and of “speciated” yeast certified reference materials for validation of measurements of target Se-containing species. Furthermore, information available on the identity of the molecules incorporating or binding Se in selenised yeast is still scarce because of the complexity of the system, the low concentration of the Se-compounds and the lack of analytical approaches allowing their identification in the absence of any suitable standards. Although the major component of Se-yeast has been identified as SeMet, the speciation studies have indicated that this food supplement is a source of other organoselenium compounds, some of which may be more potently anti-carcinogenic than SeMet. Therefore, further studies should be pursued to verify the presence of these species in the complex yeast sample.
Mass spectrometry techniques for Se speciation in vegetables from Allium family
In the case of vegetables from Allium family, the research interests have been mostly focused on Se-enriched garlic and onions.
Se-methyl-Se-cysteine (the main Se form in Se-enriched garlic) and Se-enriched garlic were shown to be more-effective anti-carcinogens than Se-yeast, in animal studies [81]. Attempts to identify the Se-containing compounds with cancer chemopreventive activity in Se-enriched garlic have led to a number of reports on Se speciation studies in these dietary supplements.
M. Kotrebai et al. [62] identified SeMC as the main compound in Se-garlic enzymatic extracts using ion-pair reversed-phase HPLC combined with ESI-MS comparing retention times and the molecular ion masses with standards. Using the same technique, γ-glutamyl-SeMC was identified in an aqueous garlic extract by the same authors [56]. Another Se compound in the garlic extract, having a molecular weight of 326 u, was attributed to γ-glutamyl-SeMet. However, lacking a matching standard, no confirmation of the identity was possible. Again, with no fragmentation of the molecular ion possible, identification is often ambiguous. The lack of compatibility of the ion-pairing reagents used in these studies with ESI could possibly hamper the on-line mass spectral confirmation of Se-compounds by ESI-MS/MS. Moreover, the complexity of the matrix and the low analyte concentration added to the difficulty of identification. The same authors found that the total Se content affects the Se distribution in samples of the same type with different Se levels. The speciation results obtained for analysis of Se-enriched garlic showed the presence of γ-glutamyl-SeMC as the main species, the same as was found in samples containing low concentration levels of Se. Moreover, the contribution of SeMC increased with the increasing total Se content [62, 82].
McSheehy et al. [82] confirmed the presence of γ-glutamyl-SeMC in a Se-containing HPLC fraction of an aqueous garlic extract after size-exclusion chromatography by ESI-MS/MS.
The presence of SeMC (as the major compound), SeMet, inorganic Se and Se(Cys)2 was reported by Bird et al. [83] using three chromatographic approaches (ion-exchange, reversed-phase and ion-pair reversed-phase HPLC) combined with ICP-MS and matching standards. However, full identification of these species detected by ICP-MS was not possible in the absence of a molecule-specific detector such as ESI-MS or ESI-MS/MS.
Selenium incorporation into onions has apparently improved the potential of these vegetables from the Allium family as a dietary source of Se compounds.SeMet, SeCys and SeMC have been identified as present in onions [79, 84]. Caruso and co-workers [79] have recently provided some evidence for the presence of Se(Cys)2, SeMC, SeMet, and inorganic Se in enzymatic extracts from combined bulbs and leaves of Se-enriched green onions (Allium fistulosum) using ion-pair reversed-phase HPLC and size-exclusion chromatography coupled with ICP-MS and matching the chromatographic retention times with commercially available standards. ESI-ion trap (IT)-MS confirmed the presence of γ-glutamyl-SeMC in green onions as has been reported in other onion types and Se-enriched garlic. In an attempt to investigate the incorporation of Se in a particular part of the plant, the leaves of Se-enriched onions (Allium cepa L.) were analysed for Se speciation by Wrobel et al. [84]. Size-exclusion HPLC-ICP-MS analysis of the plant extract obtained using sodium hydroxide showed the incorporation of Se mostly in high molecular weight fractions (apparent molecular weight higher than 10 kDa). The combination of ion-pair reversed phase HPLC with ICP-MS allowed for detection of the presence of SeMC, as the principal organoselenium species, in the enzymatic extracts of the leaves. The existence of SeMC might be relevant to the anticarcinogenic potential of Se-enriched Allium plants for the reasons mentioned above.
Characterisation of Se species in Brazil nuts by chromatography and MS techniques
Brazil nut is one of the very few consumable products with naturally occurring exceptional high levels of Se. The high bioactivity of Se from this food source for cancer prevention and selenoenzyme maintenance has been demonstrated in studies with rats [97]. In order to elucidate which species could be responsible for the disease preventive effects of Se the characterisation of Se-containing species in this dietary source of Se has been undertaken [93–98]. The low molecular weight fraction, extracted with perchloric acid from the nut matrix, was found to contain 3–15% of the total Se in different types of nuts. Proteins were dissolved with sodium hydroxide, precipitated with acetone and re-dissolved in phosphate buffer at pH 7.5 prior to Se speciation analysis using size exclusion HPLC with on-line ICP-MS. To release Se-compounds from proteins enzymatic digestion with proteinase K [96] or protein hydrolysis with methanesulphonic acid [93] were carried out. The use of ion-pair reversed-phase HPLC-ICP-MS for analysis of the enzymatic digests has led to 19–25% recovery of the total Se content in nuts (mostly found as SeMet). Better cleavage of SeMet (75% of total Se) was observed using hydrolysis with methanesulphonic acid compared to the enzymatic hydrolysis. It therefore seems probable that Brazil nuts could be a valuable dietary source of SeMet. Further studies should be pursued for identification of unknown Se species in nuts. The recent preparation of a candidate reference material from Brazil nuts (Bertholletia excelsa), which has been certified for SeMet and total Se and passed the relevant homogeneity and stability tests reccommended by BCR, may be of relevance to quality control purposes of Se speciation in this food-matrix of high-Se [94].
Outlook and future trends
Further Se speciation studies in high-Se food will be required to establish fully the links between health benefits and particular Se species. The production of new isotopically enriched Se-compounds should be pursued because it may help in the characterisation of candidate “speciated” reference materials via isotope dilution techniques and in the validation of speciation methodologies. The need to develop chromatographic separation methods that can be sequentially coupled on-line to both elemental and molecular mass spectrometry drive continued development in the field of Se speciation analysis by chromatography and MS techniques. The choice of chromatographic conditions that are fairly compatible in terms of mobile phase flow rate (μl min-1) and composition with ESI to overcome the lack of sensitivity of ESI MS will require advanced interfaces to be used between the LC system and ICP-MS. The identification of target species at low concentration levels in such complex matrices will require the development of efficient sample cleanup and preconcentration methods. The attractive features of nano-ESI MS, in terms of low sample consumption as well as a relatively high tolerance toward the presence of elevated levels of salts or buffers, may help to improve the detection power of Se compounds identification in a few microlitres of partially purified and preconcentrated HPLC fractions. Identification of unknown Se-compounds for which authentic standards are not available demands the combined use of a range of analytical techniques to elucidate their structural characteristics. Chemical and physicochemical data, in addition to the MS data, are often required to propose a reliable structure of the detected Se species. The wider use of complementary techniques (e.g. NMR) that give access to structural information is important. Confirmation of Se speciation revealed by means of chromatography and element-specific detection may involve the accurate and precise molecular mass measurement of the unknown isolated species (the better the accuracy the less the ambiguity) and of the product ions obtained from the precursor ion after CID (tandem MS). When the result of accurate mass measurement is used for empirical formula confirmation, the mass accuracy required will depend on the m/z to be measured; with increasing m/z the number of possible formulae dramatically increases making identification more and more difficult [99, 100].
References
Combs GF Jr (2001) Br J Nutr 85:517–547
Rayman MP (2002) Proc Nutr Soc 61:203–215
Levander OA (1991) J Am Diet Assoc 91:1572–1576
Rayman MP (2004) Br J Nutr 92:557–573
Levander OA (1987) Ann Rev Nutr 7:227–250
Wada O (1993) Biomed Res Trace Elem 4:227–241
B’Hymer C, Caruso J (2000) J Anal At Spectrom 15:1531–1539
Ferri T, De Luca C, Ticconi L (2001) Anal Lett 34:975–988
Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL, Parl K, Sanders BB, Smith CL, Taylor R (1996) J Am Med Assoc 276:1957–1963
Findley JW, Davis CD (2001) Biofactors 14:191–196
Whanger PD (2004) Br J Nutr 91:11–28
Spallholz JE, Palace VP, Reid TW (2004) Biochem Pharmacol 67:547–554
Spallholz JE, Shiver BJ, Reid TW (2001) Nutr Cancer 40:31–34
Ip C, Dong Y (2001) Anticancer Res 21:863–867
Findley JW, Davis CD, Feng Y (2000) J Nutr 103:2384–2389
Medina D, Thompson H, Ganther H, Ip C (2001) Nutr Cancer 40:34–41
Combs GF Jr (2004) Br J Cancer 91:195–199
Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs GF Jr, Park HK, Gross EG, Graham GF, Stratton MS, Marshall JR, Clark LC (2003) J Natl Cancer Inst 95:1477–1481
Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, Marshall JR, Clark LC (2002) Cancer Epidemiol Biomarkers Prev 11:630–639
Schrauzer GN (2000) Cell Mol Life Sci 57:1864–1873
Combs GF Jr, Gray WP (1998) Pharmacol Ther 79:179–192
Patterson BH, Levander OA (1997) Cancer Epidemiol Biomarkers Prev 6:63–69
Schrauzer GN (2001) J Am Coll Nutr 20:1–4
Levander OA (1987) Ann Rev Nutr 7:227–250
Smith AM, Picciano MF (1987) J Nutr 117:725–731
Alfthan G, Aro A, Arvilommi H, Huttunen JK (1991) Am J Clin Nutr 53:120–125
Clausen J, Nielsen SA (1988) Biol Trace Elem Res 15:125–138
Thomson CD, Robinson MF, Butler JA, Whanger PD (1993) Br J Nutr 69:577–588
Bogye G, Alfthan G, Machay T (1998) Biol Trace Elem Res 65:143–151
Kumpulainen J, Salmenpera L, Siimes MA, Koivistoinen P, Perheentupa J (1985) Am J Clin Nutr 42:829–835
Combs GF Jr, Clarck LC, Turnbull BW (2001) Biofactors 14:153–159
Ip C, Hayes C, Budnick RM, Ganther HE (1991) Cancer Res 51:595–600
Ip C, Ganther HE (1992) Carcinogenesis 13:1167–1170
Ip C, Ganther H (1990) Cancer Res 50:1206–1211
Ip C (1998) J Nutr 128:1845–1854
Dong Y, Lisk D, Block E, Ip C (2001) Cancer Res 61:2923–2928
Ogra Y, Ishiwata K, Takayama H, Aimi N, Suzuki KT (2002) J Chromatogr B 767:301–312
Huerta VD, Szpunar J, Lobinski R, Fernández Sánchez ML, Sanz-Medel A (2003) J Anal At Spectrom 18:1471–1476
Gammelgaard B, Bendahl (2004) J Anal At Spectrom 19:135–142
Bendahl, Gammelgaard B (2004) J Anal At Spectrom 19:950–957
Lobinski R, Edmonds JS, Suzuki KT, Uden PC (2000) Pure Appl Chem 72:447–461
Uden PC (2002) Anal Bioanal Chem 373:422–431
Rayman MP (2000) Lancet 356:233–241
Casiot C, Szpunar J, Lobinski R, Potin-Gautier M (1999) J Anal At Spectrom 14:645–650
Dumont E, De Cremer K, Van Hulle M, Chéry CC, Vanhaecke F, Cornelis R (2004) J Anal At Spectrom 19:167–171
Bird SM, Uden PC, Tyson JF, Block E, Denoyer E (1997) J Anal At Spectrom 12:785–788
Larsen EH, Hansen M, Paulin H, Moesgaard S, Reid M, Rayman M (2004) J AOAC Int 87:225–232
McSheehy S, Pohl P, Szpunar J, Potin-Gautier M, Lobinski R (2001) J Anal At Spectrom 16:68–73
Potalajko A, Sliwka-Kaszynska M, Dernovics M, Ruzik R, Encinar JR, Szpunar J (2004) J Anal At Spectrom 19:114–120
Encinar JR, Ouerdane L, Buchmann W, Tortajada J, Lobinski R, Szpunar J (2003) Anal Chem 75:3765–3774
Larsen EH, Sloth J, Hansen M, Moesgaard S (2003) J Anal At Spectrom 18:310–316
Uden PC, Boakye HT, Kahakachchi C, Hafezi R, Nolibos P, Block E, Johnson S, Tyson JF (2004) J Anal At Spectrom 19:65–73
Dietz C, Sanz Landaluze J, Ximénez-Embún P, Madrid-Albarrán Y, Cámara C (2004) J Anal At Spectrom 19:260–266
Monicou S, McSheehy S, Szpunar J, Potin-Gautier M, Lobinski R (2002) J Anal At Spectrom 17:15–20
Chassaigne H, Chery CC, Bordin G, Vanhaecke F, Rodríguez AR (2004) J Anal At Spectrom 19:85–95
Kotrebai M, Birringer M, Tyson JF, Block E, Uden PC (1999) Anal Commun 36:249–252
Casiot C, Vacchina V, Chassaigne H, Szpunar J, Potin-Gautier M, Lobinski R (1999) Anal Commun 36:77–80
Encinar JR, Ruzik R, Buchmann W, Tortajada J, Lobinski R, Szpunar J (2003) Analyst 128:220–224
Gilon N, Astruc A, Astruc M, Potin-Gautier M (1995) Appl Organomet 9:623–628
Díaz Huerta V, Hinojosa Reyes L, Marchante-Gayón JM, Fernández Sánchez ML, Sanz-Medel A (2003) J Anal At Spectrom 18:1243–1247
Larsen EH, Hansen M, Fan T, Vahl M (2001) J Anal At Spectrom 16:1403–1408
Kotrebai M, Birringer M, Tyson JF, Block E, Uden PC (2000) Analyst 125:71–78
Lindemann T, Hintelmann H (2002) Anal Chem 74:4602–4610
Sloth JJ, Larsen E (2000) J Anal At Spectrom 15:669–672
McSheehy S, Szpunar J, Haldys V, Tortajada J (2002) J Anal At Spectrom 17:507–514
McSheehy S, Pannier F, Szpunar J, Potin-Gautier M, Lobinski R (2002) Analyst 127:223–229
Sloth JJ, Larsen EH, Bügel SH, Moesgaard S (2003) J Anal At Spectrom 18:317–322
Yang L, Mester Z, Sturgeon R (2004) Anal Chem 76:5149–5156
Hinojosa Reyes L, Moreno Sanz F, Herrero Espílez P, Marchante-Gayón JM, García Alonso JI, Sanz-Medel A (2004) J Anal At Spectrom 19:1230–1235
Yang L, Sturgeon RE, McSheehy S, Mester Z (2004) J Chromatogr A 1055:177–184
Wolf WR, Zainal H, Yager B(2001) Fresenius J Anal Chem 370:286–290
Yang L, Sturgeon RE, Wolf WR, Goldschmidt RJ, Mester Z (2004) J Anal At Spectrom 19:1448–1453
Encinar JR, Polatajko A, Szpunnar J, Lobinski R (2004) Analyst 129:846–849
Kahakachchi C, Boakye HT, Uden PC, Tyson JF (2004) J Chromatogr A 1054:303–312
McSheehy S, Kelly J, Tessier L, Mester Z (2005) Analyst 130:35–37
Uden PC, Boakye HT, Kahakachchi C, Tyson JF (2004) J Chromatogr A 1050:85–93
El-Bayoumy K, Richie JP, Boyiri T, Komninou D, Prokopczyk B, Trushin N, Kleinman W, Cox J, Pittman B, Colosimo S (2002) Cancer Epidemiol Biomarkers Prev 11:1459–1465
Goenaga Infante H, O’Connor G, Rayman M, Wahlen R, Entwisle J, Norris P, Hearn R, Catterick T (2004) J Anal At Spectrom 19:1529–1538
Shah M, Kannamkumarath SS, Wuilloud JCA, Wuilloud RG, Caruso JA (2004) J Anal At Spectrom 19:381–386
Auger J, Yang W, Arnault I, Pannier F, Potin-Gautier M (2004) J Chromatogr A 1032:103–107
Ip C, Birringer M, Block E, Kontrebai M, Tyson JF, Uden PC, Lisk DJ (2000) J Agric Food Chem 48:2062–2070
McSheehy S, Yang W, Pannier F, Szpunar J, Lobinski R, Auger J, Potin-Gautier M (2000) Anal Chim Acta 421:147–153
Bird SM, Ge H, Uden PC, Tyson JF, Block E, Denoyer E (1997) J Chromatogr A 789:349–359
Wróbel K, Wróbel K, Kannamkumarath SS, Caruso JA, Wysocka IA, Bulska E, Świątek J, Wierzbicka M (2004) Food Chem 86:617–623
Kotrebai M, Tyson JF, Block E, Uden PC (2000) J Chromatogr A 866:51–63
Oi Y, Imafuku M, Shishido C, Kominato Y, Nishimura S, Iwaki K (2001) J Nutr 131:150–156
Ip C, Lisk DJ, Thompson HJ (1996) Carcinogenesis 17:1979–1982
Lu J, Pei H, Ip C, Lisk DJ, Ganther H, Thompson HJ (1996) Carcinogenesis 17:1903–1907
Ip C, Lisk D (1996) Adv Exp Med Biol 401:179–187
Ip C, Lisk D (1994) Carcinogenesis 15:1881–1885
Taylor PR, Parnes HL, Lippman SM (2004) J Natl Cancer Inst 96:645–647
Whanger PD, Ip C, Polan CE, Uden PC, Welbaum G (2000) J Agric Food Chem 48:5723–5730
Wrobel K, Kannamkumarath SS, Wrobel K, Caruso JA (2003) Anal Bioanal Chem 375:133–138
Bodo ET, Stefanka Z, Ipolyi I, Soros C, Dernovics M, Fodor P (2003) Anal Bioanal Chem 377:32–38
Vonderheide AP, Wrobel K, Kannamkumarath SS, B’Hymer C, Montes-Bayón M, Ponce de León C, Caruso JA (2002) J Agric Food Chem 50:5722–5728
Kannamkumarath SS, Wrobel K, Wrobel K, Vonderheide A, Caruso JA (2002) Anal Bioanal Chem 373:454–460
Ip C, Lisk DJ (1994) Nutr Cancer 21:203–212
Chang JC, Gutenmann WH, Reid CM, Lisk DJ (1995) Chemosphere 30:801–802
Gross ML (1994) J Am Soc Mass Spectrom 7:57
Bristow T, Webb K (2003) J Am Soc Mass Spectrom 14:1086–1098
Acknowledgements
The authors are most grateful to Dr. Margaret Rayman from the Centre for Nutrition and Food Safety, School of Biomedical and Molecular Sciences, University of Surrey, UK for sharing her expertise on issues of the use high-selenium yeast and its health benefits. We thank Dr. Anthony Bristow and Dr. Gavin O’Connor from LGC Limited, UK for helpful discussions on accurate mass measurements by molecular mass spectrometry. UK Department of Trade and Industry supported the work described in this paper under contract, as part of the National Measurement System Valid Analytical Measurement (VAM) program.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Infante, H.G., Hearn, R. & Catterick, T. Current mass spectrometry strategies for selenium speciation in dietary sources of high-selenium. Anal Bioanal Chem 382, 957–967 (2005). https://doi.org/10.1007/s00216-005-3177-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-005-3177-5